China Pharma Holdings, Inc. (CPHI): Price and Financial Metrics

CPHI POWR Grades

• CPHI scores best on the Sentiment dimension, with a Sentiment rank ahead of 78.44% of US stocks.
• The strongest trend for CPHI is in Momentum, which has been heading down over the past 35 weeks.
• CPHI ranks lowest in Momentum; there it ranks in the 15th percentile.

CPHI Stock Summary

• With a market capitalization of $27,455,121, China Pharma Holdings Inc has a greater market value than only 2.38% of US stocks.
• Price to trailing twelve month operating cash flow for CPHI is currently 53.88, higher than 91.51% of US stocks with positive operating cash flow.
• With a year-over-year growth in debt of 26.73%, China Pharma Holdings Inc's debt growth rate surpasses 80.87% of about US stocks.
• Stocks with similar financial metrics, market capitalization, and price volatility to China Pharma Holdings Inc are MFGP, PFIE, MGIC, JOUT, and IOSP.
• CPHI's SEC filings can be seen here. And to visit China Pharma Holdings Inc's official web site, go to www.chinapharmaholdings.com.

CPHI Valuation Summary

• CPHI's EV/EBIT ratio is -10.3; this is 135.15% lower than that of the median Healthcare stock.
• CPHI's price/earnings ratio has moved down 10.5 over the prior 154 months.
• Over the past 154 months, CPHI's price/earnings ratio has gone down 10.5.

Below are key valuation metrics over time for CPHI.

CPHI Growth Metrics

• Its year over year price growth rate is now at 20.45%.
• The 2 year revenue growth rate now stands at -27.94%.
• The 4 year cash and equivalents growth rate now stands at -93.43%.

Over the past 55 months, CPHI's revenue has gone down $5,464,813.

The table below shows CPHI's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	10.1057	0.5096	-3.811021
2021-03-31	11.46087	-0.075021	-2.973207
2020-12-31	10.86645	-0.04226	-2.866777
2020-09-30	10.98376	-1.172494	-20.403
2020-06-30	10.95993	-0.476228	-20.09405
2020-03-31	9.758618	0.273634	-20.94521

CPHI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CPHI has a Quality Grade of C, ranking ahead of 56.06% of graded US stocks.
• CPHI's asset turnover comes in at 0.493 -- ranking 88th of 677 Pharmaceutical Products stocks.
• DRNA, ONVO, and CASI are the stocks whose asset turnover ratios are most correlated with CPHI.

The table below shows CPHI's key quality metrics over time.